A Catheter-Associated Urinary Tract Infection (CAUTI) is an infection of the urinary tract that occurs in patients with an indwelling urinary catheter. It is one of the most common types of hospital-acquired or healthcare-associated infections (HAIs). These infections happen when bacteria from the patient's own body or from external sources enter the urinary tract through the catheter, colonizing the catheter and bladder. The risk of developing a CAUTI increases with the duration of catheterization. Symptoms can range from fever and chills to a burning sensation and pelvic pain. Preventing CAUTI is a major focus in healthcare and involves strict protocols such as proper hand hygiene, using sterile techniques for catheter insertion, ensuring the catheter is removed as soon as it is no longer medically necessary, and maintaining a closed drainage system.
Market Analysis: The market for preventing and treating catheter-associated urinary tract infections is experiencing significant growth due to a global focus on reducing healthcare-associated infections. In 2025, the global market for catheter infection prevention and control is valued at approximately $2.65 billion. The market is projected to reach approximately $4.1 billion by 2030, with a compound annual growth rate (CAGR) of about 9.1%. This growth is driven by the rising number of catheterized patients, increasing awareness of HAI prevention, and the development of innovative products such as antimicrobial-coated catheters and advanced urinary drainage bags. While North America currently holds the largest market share, the Asia-Pacific region is expected to show the highest growth in the coming years due to improving healthcare infrastructure and government initiatives aimed at reducing hospital-acquired infections.
